- Indication
- Mucolytic
- RAG rating
- Double Red
- Document type
- Decision document
- Place
- Hertfordshire and West Essex ICB
- Output type
- Pharmacy / Prescribing
Acetylcysteine 600mg tablets
HERTFORDSHIRE AND WEST ESSEX AREA PRESCRIBING COMMITTEE (HWE APC)
Acetylcysteine as a mucolytic for adult patients for the treatment of respiratory tract diseases
DOUBLE RED
Not recommended for prescribing in Primary, Community, Secondary or Tertiary care.
|
Name generic (trade): |
Acetylcysteine 600mg tablets |
|
What it is: |
Mucolytic in respiratory disorders |
|
Indication: |
Licensed for adults as a mucolytic agent for the treatment of respiratory tract diseases in which a reduction in bronchial secretion viscosity is required to facilitate expectoration. |
|
Date decision last revised: |
October 2025 |
HWE APC recommendation:
Acetylcysteine 600mg tablets are NOT recommended for prescribing in Primary, Community, Secondary or Tertiary care due to its high cost and lower cost alternative formulations are available.
Maybe prescribed in line with tertiary centre paediatric guidance.
- Version number
- 1.0
- Developed by
- Pharmacy and Medicines Optimisation Team, Hertfordshire and West Essex (HWE) ICB with relevant HWE ICS stakeholders
- Approved by
- Hertfordshire & West Essex Area Prescribing Committee
- Date approved / updated
- October 2025
- Review date
- This HWE APC recommendation is based upon the evidence available at the time of publication. This recommendation will be reviewed upon request in the light of new evidence becoming available.
- Superseded version